Alterations of CSF cystatin C levels and their correlations with CSF Αβ40 and Αβ42 levels in patients with Alzheimer's disease, dementia with lewy bodies and the atrophic form of general paresis
about
Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies.The Alzheimer's Prevention Clinic at Weill Cornell Medical College / New York - Presbyterian Hospital: Risk Stratification and Personalized Early Intervention.Promoting autophagic clearance: viable therapeutic targets in Alzheimer's disease.Plasma Cystatin C and High-Density Lipoprotein Are Important Biomarkers of Alzheimer's Disease and Vascular Dementia: A Cross-Sectional Study.Microwave & magnetic proteomics of macrophages from patients with HIV-associated cognitive impairment.Different cerebrospinal fluid levels of Alzheimer-type biomarker Aβ42 between general paresis and asymptomatic neurosyphilis.Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point?A mechanistic model to predict effects of cathepsin B and cystatin C on β-amyloid aggregation and degradation.Medial temporal lobe atrophy as a predictor of poor cognitive outcomes in general paresis.Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.Neuropsychiatric Features of Neurosyphilis: Frequency, Relationship with the Severity of Cognitive Impairment and Comparison with Alzheimer Disease.
P2860
Q30240101-644576A1-591B-4D35-9B44-DCD9B3D9CF32Q33697647-5F7F0C7E-000A-4A3D-AC51-FFCCA49A4220Q35064974-72CEDC05-1FBF-4E05-867A-4807DAFF256DQ37628115-426B48FE-4C34-4A0F-9830-764AD6F53FF1Q40107495-8C0B9973-E1E7-4E87-B090-578427EDE5E2Q41468427-D398970E-80DD-4D07-8B4C-468C3A975C5EQ47271759-647C8E2E-C27D-485F-95AC-72716622FFC9Q47432033-51C10742-9420-4B91-BA6C-8F21174EB9D0Q47756619-F10F3816-78D6-49F2-B2D2-BB0A9943C58DQ50666330-9822FC65-009C-431D-B91A-E3403663F912Q52093920-26E7B151-B1B4-4786-A2B9-D4A967123BA5
P2860
Alterations of CSF cystatin C levels and their correlations with CSF Αβ40 and Αβ42 levels in patients with Alzheimer's disease, dementia with lewy bodies and the atrophic form of general paresis
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Alterations of CSF cystatin C ...... rophic form of general paresis
@ast
Alterations of CSF cystatin C ...... rophic form of general paresis
@en
Alterations of CSF cystatin C ...... rophic form of general paresis
@nl
type
label
Alterations of CSF cystatin C ...... rophic form of general paresis
@ast
Alterations of CSF cystatin C ...... rophic form of general paresis
@en
Alterations of CSF cystatin C ...... rophic form of general paresis
@nl
prefLabel
Alterations of CSF cystatin C ...... rophic form of general paresis
@ast
Alterations of CSF cystatin C ...... rophic form of general paresis
@en
Alterations of CSF cystatin C ...... rophic form of general paresis
@nl
P2093
P2860
P1433
P1476
Alterations of CSF cystatin C ...... rophic form of general paresis
@en
P2093
Dong Zheng
Guo-Yan Hu
Hai-Shan Shi
Hong-Bo He
Jian-Ping Chen
Xiao-Mei Zhong
Xin-Ni Luo
Xin-Ru Chen
P2860
P304
P356
10.1371/JOURNAL.PONE.0055328
P407
P577
2013-01-29T00:00:00Z